Idelalisib

Records for this ingredient, by country (identity only).

ATC L01EM01 · 7 markets · 18 records

Idelalisib 7 markets · 18 records Forms
Filters

AU 5 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 150 mgtabletZydeligZYDELIG idelalisib 100 mg tablet bottle also in GB·US·CA
    +1Other 1 marketsFR
    unknown
  • 100 mgtabletZydeligZYDELIG idelalisib 100 mg tablet bottle also in GB·US·CA
    +1Other 1 marketsFR
    unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

GB 4 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

US 2 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

ES 2 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.